See also this year's filing and all EDGAR filings for this company.
PDF Report 0001419600_2020_Flexion_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001419600, Flexion Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 195,675,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 13,662,000 |
| 3 | remainder_Assets | 8,223,000 |
| 4 | LiabilitiesCurrent | 36,219,000 |
| 5 | LiabilitiesNoncurrent | 48,036,000 |
| 6 | remainder_Liabilities | 153,413,000 |
| 7 | CostOfGoodsAndServicesSold | 11,412,687 |
| 8 | SellingGeneralAndAdministrativeExpense | 147,341,122 |
| 9 | ResearchAndDevelopmentExpense | 76,256,921 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 324,961,968 |
| 12 | remainder_NetIncome | -21,215,897 |
| 13 | remainder_ComprehensiveNetIncome | 224,379 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 217,560,000 |
| 1 | Liabilities | 237,668,000 |
| 2 | Expenses | 235,010,730 |
| 3 | Revenues | 324,961,968 |
| 4 | StockholdersEquity | -20,108,000 |
| 5 | NetIncome | 68,735,341 |
| 6 | ComprehensiveNetIncome | 68,847,530 |
| 7 | BaseVar | 518,320,487 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.110 |
| 9 | EconomicCapitalRatio | 1.52 |
Edgar->Model Mapping
Feature Distribution
Change over Time
